<Suppliers Price>

Lulizumab Pegol

Names

[ CAS No. ]:
1421830-13-8

[ Name ]:
Lulizumab Pegol

Biological Activity

[Description]:

Lulizumab pegol (BMS-931699) is an anti-CD28 antibody antagonist. Lulizumab pegol effectively inhibits T-cell proliferation and it can be used for the reseach of kidney transplantation and autoimmunity disease[1].

[Related Catalog]:

Research Areas >> Inflammation/Immunology

[In Vitro]

BMS-931699 通过生物大分子相互作用分析系统显示出对 T 细胞增殖的 Kd 为 0.41 nM[1]。 BMS-931699 通过混合淋巴细胞反应 (MLR) 诱导的 T 细胞增殖的 EC50 为 2.9 nM 以及对全血中 CD28 受体占用 (RO) 的 EC50 为 4.4 nM[1]。

[References]

[1]. Yang Z, et al. Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699. J Pharmacol Exp Ther. 2015 Dec;355(3):506-15.  

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.